Announcement of the eighth meeting of the fourth Board of Directors

release time:

2024-12-16 16:20

AnnouncementNumber: 2024-026

Stock code: 832316                    Securities abbreviation: Tian Zheng Biotech                 Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of the eighth meeting of the fourth Board of Directors

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. The convening and attendance of the meeting
(1) Information on the convening of the meeting
1. Meeting Date: December 13, 2024
2. Meeting place: Conference room on the third floor of the company
3. Meeting mode: to be held on site
4. Time and manner of giving notice of Board meeting: by written notice on December 11, 2024
5. Meeting Moderator: Mr. CAI Tiyuan, Chairman
6. Explanation of legality and compliance of the convening situation:
The convening and convening of this meeting are in accordance with the relevant provisions of the Company Law, relevant laws, administrative regulations and the Articles of Association.
(2) Attendance at the meeting
The meeting shall be attended by 5 directors and shall be attended and authorized by 5 directors.

 

2. Deliberation of bills
(1) Deliberating and adopting the motion on changing the transfer method of the Company's shares from market-making transfer to collective bidding transfer
1. Contents of the motion:
Due to the needs of strategic development, in accordance with the Business Rules of the National SME Share Transfer System (Trial), the Guidelines for Determining and Changing the Share Transfer Method of the National SME Share Transfer System and other relevant provisions, the Company intends to apply to the National SME Share Transfer System for changing the transfer method of the Company's shares from market-making transfer to collective bidding transfer.
2. Motion voting result: 5 votes agreed; Zero votes against; There were zero abstentions.
3. Avoidance of voting:
None.
4. Submission to shareholders' meeting for voting:
This motion has yet to be submitted to the shareholders' meeting for consideration.

(2) Deliberating and passing the Motion on Submitting to the General Meeting of Shareholders to authorize the Board of Directors to handle Matters related to the Change of the Company's Share Transfer Method
1. Contents of the motion:
In order to facilitate the change of the method of stock transfer of the Company, the general meeting of shareholders of the Company is requested to authorize the Board of Directors to handle the relevant matters of the change of the method of stock transfer to the method of collective bidding. Specific contents include but are not limited to:
(1) Authorize the Board of Directors of the company to handle specific related matters in accordance with the contents of the relevant motion on changing the method of stock transfer passed by the general meeting of shareholders;
(2) Approve, sign and prepare documents related to this change in the transfer method of shares;
(3) To apply to the national SME share transfer system to change the share transfer method related matters;
(4) Handle other matters related to the change of the method of stock transfer;
(5) The authorization shall be valid from the date of approval by the general meeting of shareholders to the date of completion of the authorization matters.
2. Motion voting result: 5 votes agreed; Zero votes against; There were zero abstentions.
3. Avoidance of voting:
None.
4. Submission to shareholders' meeting for voting:
This motion has yet to be submitted to the shareholders' meeting for consideration.

(3) Deliberating and adopting the motion on proposing the convening of the Second Extraordinary General Meeting of Shareholders in 2024
1. Contents of the motion:
To request the Company to convene the second extraordinary General Meeting of 2024 on December 30, 2024 in the Company's conference room to consider the matters submitted for consideration at this general meeting.
2. Motion voting result: 5 votes agreed; Zero votes against; There were zero abstentions.
3. Avoidance of voting:
None.
4. Submission to shareholders' meeting for voting:
This motion does not need to be submitted to the General meeting for consideration.

 

3. File directory for reference
Resolution of the Eighth Meeting of the Fourth Board of Directors of Jilin Tianzheng Biotechnology Co., LTD.

 

Jilin Tianzheng Biotechnology Co., LTD
Board of directors
December 13, 2024